616 related articles for article (PubMed ID: 17510412)
41. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.
Ikegame A; Ozaki S; Tsuji D; Harada T; Fujii S; Nakamura S; Miki H; Nakano A; Kagawa K; Takeuchi K; Abe M; Watanabe K; Hiasa M; Kimura N; Kikuchi Y; Sakamoto A; Habu K; Endo M; Itoh K; Yamada-Okabe H; Matsumoto T
Leukemia; 2012 Sep; 26(9):2124-34. PubMed ID: 22430632
[TBL] [Abstract][Full Text] [Related]
42. Tumor initiating potential of side population cells in human gastric cancer.
Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
[TBL] [Abstract][Full Text] [Related]
43. Isolation of side population cells in B-cell non-Hodgkin's lymphomas.
Lee MR; Ju HJ; Kim BS; Ko YH; Kim WS; Kim SJ
Acta Haematol; 2013; 129(1):10-7. PubMed ID: 22964907
[TBL] [Abstract][Full Text] [Related]
44. Side population cells and drug resistance in breast cancer.
Wang M; Wang Y; Zhong J
Mol Med Rep; 2015 Jun; 11(6):4297-302. PubMed ID: 25647733
[TBL] [Abstract][Full Text] [Related]
45. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
Janakiraman H; Nobukiyo A; Inoue H; Kanno M
Hiroshima J Med Sci; 2011 Jun; 60(2):25-35. PubMed ID: 21970185
[TBL] [Abstract][Full Text] [Related]
46. Expression of a Hoechst 33342 efflux phenomenon and common characteristics of pluripotent stem cells in a side population of amniotic fluid cells.
Tsai YL; Chang YJ; Chou CY; Cheong ML; Tsai MS
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):139-44. PubMed ID: 20708517
[TBL] [Abstract][Full Text] [Related]
47. Breast cancer, side population cells and ABCG2 expression.
Britton KM; Eyre R; Harvey IJ; Stemke-Hale K; Browell D; Lennard TWJ; Meeson AP
Cancer Lett; 2012 Oct; 323(1):97-105. PubMed ID: 22521545
[TBL] [Abstract][Full Text] [Related]
48. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
Kim KH; Cheong HJ; Lee MY; Lee N; Lee KT; Park SK; Won JH
Anticancer Res; 2019 Jan; 39(1):127-133. PubMed ID: 30591449
[TBL] [Abstract][Full Text] [Related]
49. Breast cancer chemoresistance: emerging importance of cancer stem cells.
Chuthapisith S; Eremin J; El-Sheemey M; Eremin O
Surg Oncol; 2010 Mar; 19(1):27-32. PubMed ID: 19251410
[TBL] [Abstract][Full Text] [Related]
50. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
51. Sorting, identification and enrichment of side population cells in THP-1 acute monocytic leukemia cells.
Wang Y; Yin C; Feng L; Ma L; Wei Y; Sheng G
Oncol Rep; 2013 May; 29(5):1923-31. PubMed ID: 23450319
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells.
Seo DC; Sung JM; Cho HJ; Yi H; Seo KH; Choi IS; Kim DK; Kim JS; El-Aty AM A; Shin HC
Mol Cancer; 2007 Nov; 6():75. PubMed ID: 18034892
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
54. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
[TBL] [Abstract][Full Text] [Related]
55. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
Li D; Su D; Xue L; Liu Y; Pang W
Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
[TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of side population cells from adult human dental pulp after ischemic culture.
Wang J; Wei X; Ling J; Huang Y; Gong Q; Huo Y
J Endod; 2012 Nov; 38(11):1489-97. PubMed ID: 23063223
[TBL] [Abstract][Full Text] [Related]
57. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
58. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
[TBL] [Abstract][Full Text] [Related]
59. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.
Wang J; Guo LP; Chen LZ; Zeng YX; Lu SH
Cancer Res; 2007 Apr; 67(8):3716-24. PubMed ID: 17440084
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of cancer stem cell markers in lung carcinoma.
Zhang L; Shen L; Wu D
Acta Biochim Pol; 2021 Apr; 68(2):187-191. PubMed ID: 33877783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
